Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00390546Phase 3Completed
Phase 3, randomised, double-blind trial in supraventricular tachycardia (SVT) comparing Propranolol Arm with Digoxin Arm (2 arms). Primary endpoint: Incidence of Recurrent Supraventricular Tachycardia Requiring Medical Intervention at 6 months. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00390546.